PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.662
+0.019 (2.88%)
At close: Dec 26, 2024, 4:00 PM
0.700
+0.038 (5.82%)
Pre-market: Dec 27, 2024, 8:00 AM EST
PAVmed Market Cap
PAVmed has a market cap or net worth of $7.27 million as of December 27, 2024. Its market cap has decreased by -70.93% in one year.
Market Cap
7.27M
Enterprise Value
40.95M
1-Year Change
-70.93%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $7.27M, a decrease of -95.80%. That is a compound annual growth rate of -31.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2024 | 7.30M | -78.01% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QT Imaging Holdings | 7.64M |
| Precipio | 7.49M |
| Virax Biolabs Group | 7.47M |
| T2 Biosystems | 7.26M |
| Elevai Labs | 7.22M |
| Soligenix | 7.18M |
| GT Biopharma | 7.15M |
| Conduit Pharmaceuticals | 7.08M |